Friday, July 6, 2018
Cancer link casts pall over CRISPR - MIT Technology Review
Cancer link casts pall over CRISPR - MIT Technology Review: Reports suggesting that CRISPR could cause cancer dinged the stock prices of the big three gene editing companies: Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics all fell by 10 percent or more.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment